Literature DB >> 15116804

Caveat emptor. "Probiotics" might not be what they seem.

Brenda A Huff1.   

Abstract

OBJECTIVE: To assess whether commercially prepared probiotic products contain viable organisms, as claimed by their manufacturers, particularly whether products labeled as containing Lactobacillus did so. To identify and quantify as many species as feasible and to compare them with the contents listed on labels.
DESIGN: Randomized, double-blind trial.
SETTING: Community hospital in Chilliwack, BC. MAIN OUTCOME MEASURES: Trial of 10 randomly chosen brands of probiotic preparations bought over-the-counter in British Columbia's lower mainland. Only products claiming to contain lactobacillus were included in this study. Viable organisms in each probiotic brand and quantities of Lactobacillus in each product.
RESULTS: None of the 10 products tested matched their labeled microbiologic specifications. Two brands grew nothing aerobically or anaerobically. No Lactobacillus grew in five brands, although their labels stated that this was the main species. Eight brands contained viable cells, but only 10% of the number stated by their manufacturers.
CONCLUSION: Most product labels did not adequately identify or quantify microbes. Use of probiotics should not be recommended at this time.

Entities:  

Mesh:

Year:  2004        PMID: 15116804      PMCID: PMC2214588     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  11 in total

Review 1.  Prophylactic and therapeutic uses of probiotics: a review.

Authors:  L Kopp-Hoolihan
Journal:  J Am Diet Assoc       Date:  2001-02

2.  Probiotics plus antibiotics: regulating our bacterial environment.

Authors:  J M Saavedra
Journal:  J Pediatr       Date:  1999-11       Impact factor: 4.406

3.  The underuse of probiotics by family physicians.

Authors:  L Edmunds
Journal:  CMAJ       Date:  2001-05-29       Impact factor: 8.262

4.  Results of a double-blind, randomized study to evaluate the efficacy and safety of Antibiophilus in patients with radiation-induced diarrhoea.

Authors:  H Urbancsek; T Kazar; I Mezes; K Neumann
Journal:  Eur J Gastroenterol Hepatol       Date:  2001-04       Impact factor: 2.566

5.  In defence of the Milquetoast phenotype.

Authors:  R Beech
Journal:  Lancet       Date:  1999-05-29       Impact factor: 79.321

6.  Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial.

Authors:  S Guandalini; L Pensabene; M A Zikri; J A Dias; L G Casali; H Hoekstra; S Kolacek; K Massar; D Micetic-Turk; A Papadopoulou; J S de Sousa; B Sandhu; H Szajewska; Z Weizman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2000-01       Impact factor: 2.839

7.  Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children.

Authors:  J A Vanderhoof; D B Whitney; D L Antonson; T L Hanner; J V Lupo; R J Young
Journal:  J Pediatr       Date:  1999-11       Impact factor: 4.406

8.  "Probiotic" remedies are not what they seem.

Authors:  J M Hamilton-Miller; S Shah; C T Smith
Journal:  BMJ       Date:  1996-01-06

Review 9.  Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of published randomized, double-blind, placebo-controlled trials.

Authors:  H Szajewska; J Z Mrukowicz
Journal:  J Pediatr Gastroenterol Nutr       Date:  2001-10       Impact factor: 2.839

10.  The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy.

Authors:  A Armuzzi; F Cremonini; F Bartolozzi; F Canducci; M Candelli; V Ojetti; G Cammarota; M Anti; A De Lorenzo ; P Pola; G Gasbarrini; A Gasbarrini
Journal:  Aliment Pharmacol Ther       Date:  2001-02       Impact factor: 8.171

View more
  10 in total

1.  Supercritical CO2 interpolymer complex encapsulation improves heat stability of probiotic bifidobacteria.

Authors:  M S Thantsha; P W Labuschagne; C I Mamvura
Journal:  World J Microbiol Biotechnol       Date:  2013-08-30       Impact factor: 3.312

Review 2.  Probiotics. Some evidence of their effectiveness.

Authors:  Gregor Reid; Jo-Anne Hammond
Journal:  Can Fam Physician       Date:  2005-11       Impact factor: 3.275

Review 3.  Taking probiotics during pregnancy. Are they useful therapy for mothers and newborns?

Authors:  Gregor Reid; Pirkka Kirjaivanen
Journal:  Can Fam Physician       Date:  2005-11       Impact factor: 3.275

4.  Coming full circle: From antibiotics to probiotics and prebiotics.

Authors:  John M Conly; Lynn B Johnston
Journal:  Can J Infect Dis Med Microbiol       Date:  2004-05       Impact factor: 2.471

5.  Probiotics to prevent the need for, and augment the use of, antibiotics.

Authors:  Gregor Reid
Journal:  Can J Infect Dis Med Microbiol       Date:  2006-09       Impact factor: 2.471

6.  Characterisation of the Poly-(Vinylpyrrolidone)-Poly-(Vinylacetate-Co-Crotonic Acid) (PVP:PVAc-CA) Interpolymer Complex Matrix Microparticles Encapsulating a Bifidobacterium lactis Bb12 Probiotic Strain.

Authors:  C I Mamvura; F S Moolman; L Kalombo; A N Hall; M S Thantsha
Journal:  Probiotics Antimicrob Proteins       Date:  2011-06       Impact factor: 4.609

Review 7.  Probiotic therapy for the prevention and treatment of Clostridium difficile-associated diarrhea: a systematic review.

Authors:  Nandini Dendukuri; Vania Costa; Maurice McGregor; James M Brophy
Journal:  CMAJ       Date:  2005-07-19       Impact factor: 8.262

Review 8.  The use of probiotics in pediatric gastroenterology: a review of the literature and recommendations by Latin-American experts.

Authors:  Sylvia Cruchet; Raquel Furnes; Aldo Maruy; Eduardo Hebel; Jorge Palacios; Fernando Medina; Nelson Ramirez; Marina Orsi; Lysette Rondon; Vera Sdepanian; Luis Xóchihua; Manuel Ybarra; Roberto Arturo Zablah
Journal:  Paediatr Drugs       Date:  2015-06       Impact factor: 3.022

9.  Enumeration of Escherichia coli in Probiotic Products.

Authors:  Camille Zimmer; Caetano Dorea
Journal:  Microorganisms       Date:  2019-10-11

Review 10.  Targeting the microbiome: from probiotics to fecal microbiota transplantation.

Authors:  Alexander Khoruts
Journal:  Genome Med       Date:  2018-10-30       Impact factor: 11.117

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.